Recall Radar
All recallsMedicine & devices

Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (US…

CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

Class II Medicine & devices FDA August 12, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Zydus Pharmaceuticals (USA) Inc — Pennington, NJ
Severity
Class II — moderate
Reported
August 12, 2026
Recall number
D-0745-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide in the USA

Other medicine & devices recalls

See every current recall on the live dashboard →